Lista de obras - Pavel Jansa - Dominio Público Uruguay

Amyotrophic lateral sclerosis. Abnormal cellular inflammatory response

artículo científico publicado en 1974

Are pulmonary artery pulsatility indexes able to differentiate chronic pulmonary thromboembolism from pulmonary arterial hypertension? An echocardiographic and catheterization study

artículo científico publicado en 2010

Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial

artículo científico publicado en 2008

Cellular inflammatory response. Findings in patients with neurological diseases

artículo científico publicado en 1974

Chronic thromboembolic pulmonary hypertension

artículo científico publicado en 2013

Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry

artículo científico publicado en 2011

Chronic thromboembolic pulmonary hypertension: role of medical therapy

artículo científico publicado en 2013

Effect of macitentan on hospitalizations: results from the SERAPHIN trial

artículo científico publicado en 2014

Enzyme pattern of macrophages in the course of inflammation

artículo científico publicado en 1969

Epidemiology and long-term survival of pulmonary arterial hypertension in the Czech Republic: a retrospective analysis of a nationwide registry.

artículo científico publicado en 2014

Functional variants of eNOS and iNOS genes have no relationship to the portal hypertension in patients with liver cirrhosis

artículo científico publicado en 2013

Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension.

artículo científico publicado en 2016

Hemodynamic instability after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension correlates with cytokine network hyperstimulation.

artículo científico publicado en 2009

Implementation of a new programme for the surgical treatment of CTEPH in the Czech Republic--Pulmonary endarterectomy

artículo científico publicado en 2006

Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN

artículo científico publicado en 2015

Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry.

artículo científico publicado en 2016

Long-term results from the EARLY study of bosentan in WHO functional class II pulmonary arterial hypertension patients

artículo científico publicado en 2014

Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial.

artículo científico publicado en 2016

Macitentan and morbidity and mortality in pulmonary arterial hypertension

artículo científico publicado en 2013

Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial

artículo científico publicado en 2016

Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial.

artículo científico publicado en 2016

Pulmonary arterial hypertension associated with systemic sclerosis in the Czech Republic

artículo científico publicado en 2011

Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2).

artículo científico publicado en 2014

Risk factors for chronic thromboembolic pulmonary hypertension.

artículo científico publicado en 2008

SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension.

artículo científico publicado en 2017

Simple detection of the lupus erythematosus cell phenomenon

The course of a model cutaneous inflammation in the scapuloperoneal syndrome and in systemic neuromuscular diseases

artículo científico publicado en 1974

The phenomenon of latent pregnancy and cancer

artículo científico publicado en 1989

The phenomenon of latent pregnancy and cancer

artículo científico publicado en 1989

Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial

artículo científico publicado en 2008

Lista de obras de Pavel Jansa

Amyotrophic lateral sclerosis. Abnormal cellular inflammatory response

Are pulmonary artery pulsatility indexes able to differentiate chronic pulmonary thromboembolism from pulmonary arterial hypertension? An echocardiographic and catheterization study

Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial

Cellular inflammatory response. Findings in patients with neurological diseases

Chronic thromboembolic pulmonary hypertension

Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry

Chronic thromboembolic pulmonary hypertension: role of medical therapy

Effect of macitentan on hospitalizations: results from the SERAPHIN trial

Enzyme pattern of macrophages in the course of inflammation

Epidemiology and long-term survival of pulmonary arterial hypertension in the Czech Republic: a retrospective analysis of a nationwide registry.

Functional variants of eNOS and iNOS genes have no relationship to the portal hypertension in patients with liver cirrhosis

Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension.

Hemodynamic instability after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension correlates with cytokine network hyperstimulation.

Implementation of a new programme for the surgical treatment of CTEPH in the Czech Republic--Pulmonary endarterectomy

Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN

Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry.

Long-term results from the EARLY study of bosentan in WHO functional class II pulmonary arterial hypertension patients

Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial.

Macitentan and morbidity and mortality in pulmonary arterial hypertension

Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial

Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial.

Pulmonary arterial hypertension associated with systemic sclerosis in the Czech Republic

Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2).

Risk factors for chronic thromboembolic pulmonary hypertension.

SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension.

Simple detection of the lupus erythematosus cell phenomenon

The course of a model cutaneous inflammation in the scapuloperoneal syndrome and in systemic neuromuscular diseases

The phenomenon of latent pregnancy and cancer

The phenomenon of latent pregnancy and cancer

Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial